Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Lyka Labs Limited (NSE: LYKALABS), ISIN INE933A01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
LYKALABS last traded at ₹79.01 (+0.50%), with a 52-week range of ₹44.10 to ₹95.46 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 58.45%, FIIs 0.15%, DIIs 0.66%, mutual funds 0.01%.
EquiSense Score (ECS): 55/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.